# KALV (KalVista Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> KalVista Pharmaceuticals, Inc. reported $328.9M in total assets and a net loss of $183.4M through April 30, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/KALV
- Markdown: https://convexityos.com/fundamentals/KALV.md
- SEC CIK: 0001348911
- Reporting currency: USD
- Latest filing period: March 31, 2026
- Last synced: Nov 20, 2026, 05:26 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001348911&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Apr 30, 2025 |
| Operating Income | FY 2025 | -$188.0M | Operating profit |
| Net Income | FY 2025 | -$183.4M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$3.69 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$153.3M | Operating CF less CapEx |
| Cash & ST Investments | Mar 31, 2026 | $285.0M | Total debt: $184.3M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | $50.00M | -- | -- | -- | $12.69M | $16.13M | $8.39M | $1.50M | $2.13M |
| Research & Development | $71.71M | $86.17M | $80.28M | $70.17M | $41.29M | $40.19M | $35.02M | $18.24M | $12.67M | $14.66M |
| Total Operating Expenses | $188.0M | $140.4M | $110.9M | $96.61M | $57.92M | $53.22M | $45.95M | $27.10M | $23.84M | $17.31M |
| **Operating Income** | -$188.0M | -$140.4M | -$110.9M | -$96.61M | -$57.92M | -$40.53M | -$29.82M | -$18.70M | -$22.34M | -$15.18M |
| **EBITDA** | -$187.1M | -$139.6M | -$110.2M | -$96.05M | -$57.39M | -$40.02M | -$29.44M | -$18.52M | -$22.30M | -$15.15M |
| Interest Income | $6.43M | $3.90M | $2.23M | $1.09M | $903K | $1.83M | $1.40M | $82K | $36K | $50K |
| Interest Expense | $5.79M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Income Before Tax | -$180.1M | -$126.6M | -$92.91M | -$82.34M | -$82.34M | -$29.24M | -$20.69M | -$15.80M | -$18.60M | -$11.44M |
| Income Tax Expense | $3.39M | $0 | $0 | $0 | $0 | -$124K | $124K | $0 | $0 | $0 |
| **Net Income** | -$183.4M | -$126.6M | -$92.91M | -$82.34M | -$46.24M | -$29.12M | -$20.82M | -$15.80M | -$18.60M | -$11.44M |
| Basic EPS | -$3.69 | -$3.44 | -$3.33 | -$3.36 | -$2.42 | -$1.64 | -$1.38 | -$1.53 | -$4.47 | -$26.17 |
| **Diluted EPS** | -$3.69 | -$3.44 | -$3.33 | -$3.36 | -$2.42 | -$1.64 | -$1.38 | -$1.53 | -$4.47 | -$26.17 |
| Basic Shares Outstanding | 49.7M | 36.8M | 27.9M | 24.5M | 19.1M | 17.7M | 15.1M | 10.3M | 4.6M | 591.3K |
| Diluted Shares Outstanding | 49.7M | 36.8M | 27.9M | 24.5M | 19.1M | 17.7M | 15.1M | 10.3M | 4.6M | 591.3K |

### Income Statement (Quarterly)

| Line Item | Mar 2026 | Sep 2025 | Jul 2025 | Jun 2025 | Apr 2025 | Mar 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $40.86M | $13.70M | $1.40M | -- | -- | -- | -- | -- |
| Cost of Revenue | $3.09M | $1.23M | -- | -- | -- | -- | -- | -- |
| **Gross Profit** | $37.77M | $12.47M | -- | -- | -- | -- | -- | -- |
| Research & Development | $12.42M | $11.99M | $15.16M | -- | $15.89M | $14.17M | $12.59M | $16.61M |
| Selling, General & Admin | $48.80M | $46.52M | $44.68M | -- | -- | $35.53M | -- | -- |
| Total Operating Expenses | $64.31M | $59.74M | $60.44M | -- | $55.03M | $49.71M | $42.94M | $45.81M |
| **Operating Income** | -$23.44M | -$46.05M | -$59.01M | -- | -$55.03M | -$49.71M | -$42.94M | -$45.81M |
| **EBITDA** | -$23.09M | -- | -$58.76M | -- | -$54.77M | -$49.46M | -$42.71M | -$45.58M |
| Interest Income | $2.55M | $1.88M | $1.85M | -- | $1.99M | $1.74M | $1.39M | $1.36M |
| Interest Expense | $5.59M | $4.76M | $3.52M | -- | -- | $2.94M | -- | -- |
| Income Before Tax | -$23.49M | -$47.33M | -$57.94M | -- | -$53.08M | -$47.59M | -$44.26M | -- |
| Income Tax Expense | $0 | $2.16M | $2.16M | -- | -$855K | $4.25M | $4.25M | -- |
| **Net Income** | -$23.49M | -$49.48M | -$60.10M | -$57.60M | -$52.23M | -$51.84M | -$48.51M | -$42.27M |
| Basic EPS | -$0.43 | -$0.92 | -$1.12 | -- | -- | -$0.98 | -$0.92 | -$0.91 |
| **Diluted EPS** | -$0.43 | -$0.92 | -$1.12 | -- | -- | -$0.98 | -$0.92 | -$0.91 |
| Basic Shares Outstanding | 54.6M | 53.9M | 53.5M | -- | -- | 53.1M | 52.6M | 46.7M |
| Diluted Shares Outstanding | 54.6M | 53.9M | 53.5M | -- | -- | 53.1M | 52.6M | 46.7M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $131.6M | $31.79M | $56.24M | $30.73M | $50.59M | $15.79M | $32.01M | $51.05M | $30.95M | $21.76M |
| Short-Term Investments | $89.00M | $178.6M | $93.14M | $135.5M | $198.3M | $51.92M | $68.81M | -- | -- | -- |
| **Cash & Short-Term Investments** | $220.6M | $210.4M | $149.4M | $166.2M | $248.9M | $67.71M | $100.8M | $51.05M | $30.95M | $21.76M |
| Accounts Receivable, Net | $0 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Assets** | $241.7M | $225.7M | $172.3M | $193.6M | $264.3M | $88.70M | $115.5M | $59.38M | $34.20M | $24.67M |
| Property, Plant & Equipment, Net | $1.99M | $2.23M | $2.95M | $2.18M | $1.79M | $2.04M | $2.41M | $1.84M | $97K | $74K |
| Other Non-Current Assets | $1.55M | $567K | $106K | $193K | $200K | $178K | $173K | $173K | $50K | -- |
| **Total Non-Current Assets** | $9.08M | $9.71M | $10.88M | $10.23M | $7.75M | $3.83M | $2.59M | $2.01M | $147K | $74K |
| **Total Assets** | $250.8M | $235.4M | $183.2M | $203.9M | $272.0M | $92.53M | $118.1M | $61.39M | $34.34M | $24.75M |
| Accounts Payable | $4.88M | $9.11M | $4.82M | $3.64M | $1.98M | $1.68M | $2.86M | $1.43M | $1.15M | $1.01M |
| Deferred Revenue (Current) | $11.00M | -- | -- | -- | -- | -- | $9.54M | $18.48M | -- | -- |
| **Total Current Liabilities** | $45.17M | $22.81M | $15.03M | $11.58M | $9.77M | $7.72M | $18.05M | $23.22M | $3.02M | $3.25M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | $3.34M | $10.86M | -- | -- |
| **Total Non-Current Liabilities** | $110.2M | $6.01M | $7.14M | $7.21M | $5.05M | $1.06M | $3.34M | $10.92M | $0 | $0 |
| **Total Liabilities** | $155.4M | $28.82M | $22.18M | $18.79M | $14.82M | $8.78M | $21.39M | $34.14M | $3.02M | $3.25M |
| **Total Debt (incl. Leases)** | $6.31M | $7.32M | $8.23M | $8.19M | $5.91M | $1.65M | -- | -- | -- | -- |
| Common Stock | $50K | $42K | $34K | $25K | $24K | $18K | $17K | $11K | $10K | -- |
| Retained Earnings | -$653.2M | -$469.7M | -$343.1M | -$250.2M | -$167.8M | -$121.6M | -$92.48M | -$71.66M | -$55.85M | -$37.25M |
| Accumulated Other Comp. Income | -$5.21M | -$3.49M | -$3.06M | -$3.86M | -$1.43M | -$1.88M | -$1.93M | -$1.11M | -$2.64M | -$75K |
| **Total Stockholders' Equity** | $95.39M | $206.6M | $161.0M | $185.1M | $257.2M | $83.75M | $96.74M | $27.25M | $31.33M | -$37.11M |
| Total Equity | $95.39M | $206.6M | $161.0M | $185.1M | $257.2M | $83.75M | $96.74M | $27.25M | $31.33M | -$37.11M |

### Balance Sheet (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Dec 2024 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $213.8M | $229.3M | $243.5M | $124.3M | $131.6M | $167.3M | $182.3M | $41.58M |
| Short-Term Investments | $71.26M | $70.87M | $65.66M | $67.16M | $89.00M | $85.92M | $86.02M | $94.19M |
| **Cash & Short-Term Investments** | $285.0M | $300.2M | $309.2M | $191.5M | $220.6M | $253.2M | $268.3M | $135.8M |
| Accounts Receivable, Net | $9.90M | $2.59M | $5.78M | $1.93M | $0 | -- | $0 | -- |
| Inventory | $4.00M | $3.43M | $458K | -- | -- | -- | -- | -- |
| **Total Current Assets** | $314.2M | $320.1M | $325.2M | $205.9M | $241.7M | $267.4M | $286.0M | $152.3M |
| Property, Plant & Equipment, Net | $2.84M | $3.03M | $3.19M | $2.07M | $1.99M | $1.81M | $1.88M | $2.04M |
| Other Non-Current Assets | $2.45M | $2.37M | $2.42M | $2.38M | $1.55M | $1.39M | $1.38M | $662K |
| **Total Non-Current Assets** | $14.71M | $15.23M | $14.71M | $9.61M | $9.08M | $8.63M | $8.84M | $8.56M |
| **Total Assets** | $328.9M | $335.4M | $339.9M | $215.5M | $250.8M | $276.0M | $294.8M | $160.8M |
| Accounts Payable | $8.04M | $8.27M | $8.07M | $5.87M | $4.88M | $5.86M | $5.73M | $5.20M |
| Deferred Revenue (Current) | $833K | -- | $11.51M | $11.41M | $11.00M | -- | -- | -- |
| **Total Current Liabilities** | $60.82M | $57.35M | $45.07M | $38.38M | $45.17M | $25.61M | $26.11M | $22.16M |
| Long-Term Debt | $172.2M | -- | -- | -- | -- | -- | -- | -- |
| Deferred Revenue (Non-Current) | $21.36M | $11.71M | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $287.8M | $280.7M | $277.9M | $136.3M | $110.2M | $105.3M | $104.3M | $4.67M |
| **Total Liabilities** | $348.6M | $338.1M | $322.9M | $174.7M | $155.4M | $130.9M | $130.5M | $26.84M |
| **Total Debt (incl. Leases)** | $184.3M | $12.35M | $10.56M | $6.14M | $6.31M | $5.78M | $5.89M | $5.78M |
| Common Stock | $51K | $51K | $50K | $50K | $50K | $49K | $49K | $43K |
| Retained Earnings | -$786.2M | -$762.7M | -$739.1M | -$713.3M | -$653.2M | -$600.9M | -$580.2M | -$552.4M |
| Accumulated Other Comp. Income | -$7.12M | -$7.13M | -$6.73M | -$6.39M | -$5.21M | -$2.21M | -$2.42M | -$2.70M |
| **Total Stockholders' Equity** | -$19.65M | -$2.71M | $17.00M | $40.79M | $95.39M | $145.1M | $164.4M | $134.0M |
| Total Equity | -$19.65M | -$2.71M | $17.00M | $40.79M | $95.39M | $145.1M | $164.4M | $134.0M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$183.4M | -$126.6M | -$92.91M | -$82.34M | -$46.24M | -$29.12M | -$20.82M | -$15.80M | -$18.60M | -$11.44M |
| Depreciation & Amortization | $941K | $816K | $718K | $564K | $537K | $512K | $378K | $180K | $40K | $33K |
| Stock-Based Compensation | $12.29M | $21.91M | $9.92M | $11.09M | $7.12M | $4.45M | $2.97M | $1.06M | $394K | $118K |
| Change in Payables | -$4.97M | $4.32M | $1.11M | $1.69M | $150K | -$1.00M | $1.53M | $217K | -$1.60M | $374K |
| **Operating Cash Flow** | -$152.9M | -$89.23M | -$75.26M | -$78.13M | -$30.17M | -$44.82M | -$36.37M | $10.56M | -$23.72M | -$13.16M |
| Capital Expenditure | -$434K | -$42K | -$1.20M | -$931K | -$82K | -$220K | -$1.08M | -$1.43M | -$74K | -$11K |
| **Free Cash Flow** | -$153.3M | -$89.27M | -$76.46M | -$79.06M | -$30.25M | -$45.04M | -$37.45M | $9.13M | -$23.80M | -$13.17M |
| Purchases of Investments | -$30.57M | -$189.2M | -$98.25M | -$136.9M | -$201.2M | -$49.80M | -$79.89M | -- | -- | -- |
| **Investing Cash Flow** | $91.02M | -$84.72M | $41.41M | $57.86M | -$147.7M | $16.75M | -$69.42M | -$1.43M | $34.06M | -$11K |
| Common Stock Issued | $55.91M | $96.94M | $56.58M | -- | $210.6M | $11.42M | $87.91M | $9.14M | $2.0K | $1.0K |
| **Financing Cash Flow** | $159.7M | $150.7M | $58.12M | $1.58M | $212.1M | $11.58M | $87.94M | $8.99M | $2.0K | $33.00M |
| **Net Change in Cash** | $100.5M | -$24.45M | $25.51M | -$19.86M | $34.80M | -$16.22M | -$19.05M | $20.11M | $9.19M | $19.24M |

### Cash Flow Statement (Quarterly)

| Line Item | Mar 2026 | Sep 2025 | Jul 2025 | Jun 2025 | Apr 2025 | Mar 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$23.49M | -$49.48M | -$60.10M | -$57.60M | -$52.23M | -$51.84M | -$48.51M | -$42.27M |
| Depreciation & Amortization | $355K | -- | $252K | -- | $261K | $251K | $229K | $227K |
| Stock-Based Compensation | $5.07M | -- | $5.38M | -- | $3.64M | $3.24M | $2.61M | $3.00M |
| Change in Receivables | -$7.32M | -- | -$1.93M | -- | -- | -- | -- | -- |
| Change in Inventory | -$665K | -- | -- | -- | -- | -- | -- | -- |
| Change in Payables | -$149K | -- | $2.51M | -- | -$1.39M | -$3.12M | $779K | -$5.86M |
| **Operating Cash Flow** | -$14.46M | -- | -$54.50M | -- | -$40.36M | -$47.57M | -$32.68M | -$39.64M |
| Capital Expenditure | -$121K | -- | -$290K | -- | -$281K | -$288K | -$24K | -$108K |
| **Free Cash Flow** | -$14.58M | -- | -$54.79M | -- | -$40.65M | -$47.85M | -$32.70M | -$39.75M |
| Purchases of Investments | -$16.43M | -- | -$19.98M | -- | -$23.02M | -$23.49M | -$6.56M | -$1.0K |
| **Investing Cash Flow** | -$901K | -- | $21.26M | -- | -$3.33M | -$3.72M | $8.52M | $48.67M |
| **Financing Cash Flow** | $1.47M | -- | $23.21M | -- | $4.66M | $2.22M | $151.8M | $295K |
| **Net Change in Cash** | -$15.57M | -- | -$7.31M | -- | -$35.67M | -$46.82M | $126.4M | $9.73M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -280.9% | -- | -- | -- | -319.4% | -184.9% | -222.8% | -1485.3% | -711.7% |
| **Net Profit Margin** | -- | -253.3% | -- | -- | -- | -229.4% | -129.1% | -188.3% | -1236.9% | -536.1% |
| Return on Equity (ROE) | -192.3% | -61.3% | -57.7% | -44.5% | -18.0% | -34.8% | -21.5% | -58.0% | -59.4% | -- |
| Return on Assets (ROA) | -73.2% | -53.8% | -50.7% | -40.4% | -17.0% | -31.5% | -17.6% | -25.7% | -54.2% | -46.2% |
| Current Ratio | 5.35x | 9.90x | 11.46x | 16.73x | 27.04x | 11.49x | 6.40x | 2.56x | 11.33x | 7.59x |
| Quick Ratio | 4.88x | 9.23x | 9.94x | 14.36x | 25.47x | 8.77x | 5.58x | 2.20x | 10.26x | 6.70x |
| Debt to Equity | 0.07x | 0.04x | 0.05x | 0.04x | 0.02x | 0.02x | -- | -- | -- | -- |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -- | -21.3% | +92.1% | +458.1% | -29.5% | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -444.4% | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -510.1% | -- | -- | -- |
| 5Y Revenue / Share Growth | -- | +27.1% | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Mar 2026 | Sep 2025 | Jul 2025 | Jun 2025 | Apr 2025 | Mar 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -58.0% | -- | -- | -- | -- | -- | -- | -- |
| Current Ratio | 5.17x | 7.22x | 5.37x | 5.37x | 5.35x | 5.35x | 10.44x | 6.87x |
| Quick Ratio | 5.10x | 7.21x | 5.04x | 5.04x | 4.88x | 4.88x | 9.88x | 6.13x |
| Debt to Equity | -- | 0.62x | 0.15x | 0.15x | 0.07x | 0.07x | 0.04x | 0.04x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
